🇺🇸 FDA
Patent

US 9993503

Methods for production of platelets from pluripotent stem cells and compositions thereof

granted A61KA61K35/19A61P

Quick answer

US patent 9993503 (Methods for production of platelets from pluripotent stem cells and compositions thereof) held by Astellas Institute for Regenerative Medicine expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Astellas Institute for Regenerative Medicine
Grant date
Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K35/19, A61P, A61P17/02, A61P33/06